Bio-Key International (BKYI) closed at $2.85 on October 26, 2026, down 15.9% from the previous close, on volume of 650,934 shares (30-day average 10,979,493).
Data as of October 26, 2026.
BIO-key rallies after a new Middle East government adopts PortalGuard and FIDO2 Passkey:YOU
Market Chameleon (Fri, 23-Oct 5:53 AM ET)
Why Is Penny Stock BIO-key International (BKYI) Up 38% Today?
TipRanks (Thu, 22-Oct 12:10 PM ET)
BKYI rallies after landing an undisclosed Gulf government deployment for passwordless biometrics
Market Chameleon (Thu, 22-Oct 6:57 AM ET)
Globe Newswire (Thu, 22-Oct 3:59 AM ET)
BIO-key taps Stephen Morrow to lead PortalGuard as Passkey:YOU reaches FIDO certification
Market Chameleon (Tue, 13-Oct 6:24 AM ET)
Globe Newswire (Tue, 13-Oct 8:29 AM ET)
BIO-key Adds New Middle East Government Security Agency Customer, Expanding Regional Footprint
Globe Newswire (Tue, 13-Oct 4:01 AM ET)
BIO-key Partners with Al Majlis Group to Expand Identity Security Across Arabian Gulf
Globe Newswire (Tue, 29-Sep 3:30 AM ET)
Globe Newswire (Wed, 23-Sep 7:59 AM ET)
Globe Newswire (Tue, 1-Sep 7:59 AM ET)
BIO-key International Inc is a identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and high-quality, low-cost accessory fingerprint scanner and FIDO-compliant hardware to provide a full and complete solution for identity-innovating customers. The company operates as one operating segment. Its solutions are Passwordless Authentication, Secure Roving Employees, Education, Financial Services, Government, Healthcare, Manufacturing, etc.
Bio-Key International trades on the NASDAQ stock market under the symbol BKYI.
As of October 27, 2026, BKYI stock price declined to $2.70 with 114,050 million shares trading.
BKYI has a beta of -7.44, meaning it tends to be less sensitive to market movements. BKYI has a correlation of 0.26 to the broad based SPY ETF.
BKYI has a market cap of $5.49 million. This is considered a Sub-Micro Cap stock.
Last quarter Bio-Key International reported $2 million in Revenue and -$.56 earnings per share. This beat revenue expectation by $120,000 and exceeded earnings estimates by $.26.
BKYI support price is $2.43 and resistance is $3.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BKYI shares will trade within this expected range on the day.
